Effects of liver-targeted drugs on expression of immune-related proteins in hepatocellular carcinoma cells

Conclusion Lenvatinib and regorafenib affected the expression of PD-L1 in the process of anti-HCC.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research